PAKISTAN
VETERINARY
JOURNAL
     
 
previous page   Pak Vet J, 2026, 46(2) 460-467   next page
 
SIRT1 Inhibits Bovine Cartilage ECM Degradation and Apoptosis by Activating Nrf2/HO-1 and Inhibiting NF-κB Pathways
 
Zongsheng Qiu 1†, Jingjing Qi1†, Xiaoyan Guo 1, Tiantian Gao 1, Hui Bai 2, Chengwei Wei 1, Zhiheng Zhang 2, Yanan Li 1,3, Yuhui Ma 3, Jiantao Zhang 1 and Tianwen Ma 1,3*

1Heilongjiang Key Laboratory for Laboratory Animals and Comparative Medicine, College of Veterinary Medicine, Northeast Agricultural University, Harbin 150030, China; 2 College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010000, China; 3 Zhaosu County Xiyu Horse Industry Co., Ltd., Zhaosu 835500, China. † Zongsheng Qiu and Jingjing Qi contributed equally to this work.

*Corresponding author: dnmatianwen@163.com

Abstract   

This study explored the potential mechanism of SIRT1 in bovine osteoarthritis (OA). In vivo experiments evaluated the severity of damage to bovine tarsal cartilage tissue through pathological staining and Mankin scoring. When compared with healthy bovines, cartilage in OA-affected bovines displayed ECM degradation and increased Mankin scores (P<0.01). In the cartilage of OA-affected cattle, the protein expression of inflammatory factors (TNF-α, IL-1β, COX-2) and ECM degradation markers (MMP-3, MMP-13) was increased (P<0.05), the expression levels of key pathway proteins (including SIRT1, nuclear Nrf2 and HO-1) were decreased (P<0.05), and the expression of nuclear p65 and p-IκBα was upregulated (P<0.05). In vitro studies, we developed a bovine primary chondrocyte inflammation model using 10ng/mL IL-1β. IL-1β treatment significantly upregulated the expression levels of ECM degradation markers in chondrocytes (P<0.01). Transmission electron microscopy revealed mitochondrial ultrastructural damage, and flow cytometry indicated an apoptosis rate of 38.1%. ML334 treatment significantly enhanced the levels of nuclear Nrf2, HO-1, and Bcl-2 (P<0.05), while simultaneously decreasing nuclear p65, BAX, Cleaved caspase-3, and ECM degradation markers (P<0.05). JSH-23 treatment successfully downregulated nuclear p65 and ECM degradation marker levels (P<0.05). Treatment with the SIRT1 agonist SRT2104 not only increased the level of SIRT1, nuclear Nrf2, and HO-1 (P<0.05), but also effectively attenuated the expression of nuclear p65 (P<0.05). This experiment strongly supports the claim that SIRT1 effectively protects bovine cartilage ECM from degradation and apoptosis through a dual mechanism of action (activation of the Nrf2/HO-1 pathway and inhibition of the NF-κB pathway).

To Cite This Article: Qiu Z, Qi J, Guo X, Gao T, Bai H, Wei C, Zhang Z, Li Y, Ma Y, Zhang J and Ma T, 2026. SIRT1 inhibits bovine cartilage ECM degradation and apoptosis by activating Nrf2/HO-1 and inhibiting NF-κB pathways. Pak Vet J, 46(2): 460-467. http://dx.doi.org/10.29261/pakvetj/2026.034

 
 
   
 

ISSN 0253-8318 (Print)
ISSN 2074-7764 (Online)



scopus
 
DOI
 
DOAJ SEAL
  
SCImago Journal & Country Rank